As for Lilly ( LLY ), Bernstein said its outperform rating “hinges on what they can do with the cash they generate from ...

Here are seven pharmaceutical stocks to buy with dividends of at least 2%, according to Bank of America: ...

High-quality dividend stocks like AbbVie ABBV, Amgen AMGN and Gilead Sciences GILD with an impressive dividend history, might fetch promising returns for investors.These companies have ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Analyst Michael Yee from Jefferies maintained a Buy rating on Gilead Sciences (GILD – Research Report) and keeping the price target at ...

Jefferies analyst Michael Yee maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $95.00.

With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, ...

IBT’s top ten include two large biotechs (Amgen and Gilead Sciences) together with eight smaller biotechs including Horizon and Vertex. These three trusts have rather different yields ...

PORTLAND, CA, UNITED STATES, October 7, 2024 /EINPresswire / -- According to the report, the global cancer gene therapy <a target=_blank href=ht ...

BMO chief investment strategist Brian Belski provided an update on his popular North American Dividend Growth portfolio, ...

Amgen is one of the world’s largest biotechnology ... which closed at $54.92 on Oct. 14. Gilead Sciences is a biopharmaceutical company that develops treatments for HIV/AIDS, hepatitis C ...